7TY3 | pdb_00007ty3

Crystal Structure of SETD2 Bound to an Indole-based Inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free: 
    0.270 (Depositor), 0.277 (DCC) 
  • R-Value Work: 
    0.214 (Depositor), 0.219 (DCC) 
  • R-Value Observed: 
    0.216 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 7TY3

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical Studies.

Alford, J.S.Lampe, J.W.Brach, D.Chesworth, R.Cosmopoulos, K.Duncan, K.W.Eckley, S.T.Kutok, J.L.Raimondi, A.Riera, T.V.Shook, B.Tang, C.Totman, J.Farrow, N.A.

(2022) ACS Med Chem Lett 13: 1137-1143

  • DOI: https://doi.org/10.1021/acsmedchemlett.2c00167
  • Primary Citation Related Structures: 
    7TY2, 7TY3

  • PubMed Abstract: 

    SETD2, a lysine N -methyltransferase, is a histone methyltransferase that plays an important role in various cellular processes and was identified as a target of interest in multiple myeloma that features a t(4,14) translocation. We recently reported the discovery of a novel small-molecule SETD2 inhibitor tool compound that is suitable for preclinical studies. Herein we describe the conformational-design-driven evolution of the advanced chemistry lead, which resulted in compounds appropriate for clinical evaluation. Further optimization of this chemical series led to the discovery of EZM0414, which is a potent, selective, and orally bioavailable inhibitor of SETD2 with good pharmacokinetic properties and robust pharmacodynamic activity in a mouse xenograft model.


  • Organizational Affiliation
    • Epizyme Inc., 50 Hampshire Street, Sixth Floor, Cambridge, Massachusetts 02139, United States.

Macromolecule Content 

  • Total Structure Weight: 33.01 kDa 
  • Atom Count: 2,016 
  • Modeled Residue Count: 238 
  • Deposited Residue Count: 278 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Histone-lysine N-methyltransferase SETD2278Homo sapiensMutation(s): 0 
Gene Names: SETD2HIF1HYPBKIAA1732KMT3ASET2HSPC069
EC: 2.1.1.359 (PDB Primary Data), 2.1.1 (PDB Primary Data)
UniProt & NIH Common Fund Data Resources
Find proteins for Q9BYW2 (Homo sapiens)
Explore Q9BYW2 
Go to UniProtKB:  Q9BYW2
PHAROS:  Q9BYW2
GTEx:  ENSG00000181555 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ9BYW2
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 4 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
KRF
(Subject of Investigation/LOI)

Query on KRF



Download:Ideal Coordinates CCD File
F [auth A]N-[(1R,3R)-3-(4-acetylpiperazin-1-yl)cyclohexyl]-4-fluoro-7-methyl-1H-indole-2-carboxamide
C22 H29 F N4 O2
PGNLXEBQMQHFNK-IAGOWNOFSA-N
SAM

Query on SAM



Download:Ideal Coordinates CCD File
E [auth A]S-ADENOSYLMETHIONINE
C15 H22 N6 O5 S
MEFKEPWMEQBLKI-FCKMPRQPSA-N
ZN

Query on ZN



Download:Ideal Coordinates CCD File
B [auth A],
C [auth A],
D [auth A]
ZINC ION
Zn
PTFCDOFLOPIGGS-UHFFFAOYSA-N
EDO

Query on EDO



Download:Ideal Coordinates CCD File
G [auth A]1,2-ETHANEDIOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
KRF BindingDB:  7TY3 IC50: min: 1240, max: 2000 (nM) from 2 assay(s)

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free:  0.270 (Depositor), 0.277 (DCC) 
  • R-Value Work:  0.214 (Depositor), 0.219 (DCC) 
  • R-Value Observed: 0.216 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 52.092α = 90
b = 76.702β = 90
c = 75.461γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
Aimlessdata scaling
PDB_EXTRACTdata extraction
XDSdata reduction

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data

  • Released Date: 2022-08-31 
  • Deposition Author(s): Farrow, N.A.

Funding OrganizationLocationGrant Number
Not funded--

Revision History  (Full details and data files)

  • Version 1.0: 2022-08-31
    Type: Initial release
  • Version 1.1: 2024-02-21
    Changes: Data collection
  • Version 1.2: 2024-04-03
    Changes: Refinement description